Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tohru Takeuchi

Showing results (81-90 of 125) with videos related to

Pageof 13
Sort By:
The Journal of Rheumatology|May 2, 2022
Association of M2 Macrophages, Th2, and B Cells With Pathomechanism in Microscopic Polyangiitis Complicated by Interstitial Lung DiseaseShogo Matsuda, Takuya Kotani, Hiroko Kuwabara, et al.
Rheumatology (Oxford, England)|January 25, 2021
CCL2 produced by CD68+/CD163+ macrophages as a promising clinical biomarker of microscopic polyangiitis-interstitial lung diseaseShogo Matsuda, Takuya Kotani, Hiroko Kuwabara, et al.
Rheumatology (Oxford, England)|August 26, 2023
Prediction model for respiratory-related mortality in microscopic polyangiitis with interstitial lung disease: multicentre REVEAL cohort studyShogo Matsuda, Takuya Kotani, Ayana Okazaki, et al.
Arthritis Research & Therapy|November 21, 2023
Risk prediction model for mortality in microscopic polyangiitis: multicentre REVEAL cohort studyTakuya Kotani, Shogo Matsuda, Ayana Okazaki, et al.
Rheumatology (Oxford, England)|July 20, 2019
Exploration of pathomechanism using comprehensive analysis of serum cytokines in polymyositis/dermatomyositis-interstitial lung diseaseShogo Matsuda, Takuya Kotani, Takaaki Ishida, et al.
Arthritis Research & Therapy|April 16, 2021
Comparison of the drug retention and reasons for discontinuation of tumor necrosis factor inhibitors and interleukin-6 inhibitors in Japanese patients with elderly-onset rheumatoid arthritis-the ANSWER cohort studySadao Jinno, Akira Onishi, Maureen Dubreuil, et al.
Scientific Reports|January 16, 2021
Evaluation of poor prognostic factors of respiratory related death in microscopic polyangiitis complicated by interstitial lung diseaseShogo Matsuda, Takuya Kotani, Takayasu Suzuka, et al.
Arthritis Research & Therapy|December 20, 2024
Poor prognostic factors for relapse of interstitial lung disease in microscopic polyangiitis: the Japanese multicentre REVEAL cohort studyShogo Matsuda, Takuya Kotani, Ayana Okazaki, et al.
Rheumatology International|July 31, 2020
Comparison of the efficacy and safety of biologic agents between elderly-onset and young-onset RA patients: the ANSWER cohort studySadao Jinno, Akira Onishi, Maureen Dubreuil, et al.
Clinical Rheumatology|March 13, 2020
Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort studyKosuke Ebina, Toru Hirano, Yuichi Maeda, et al.
Pageof 13

Showing results (81-90 of 125) with videos related to

Sort By:
Pageof 13
The Journal of Rheumatology|May 2, 2022
Association of M2 Macrophages, Th2, and B Cells With Pathomechanism in Microscopic Polyangiitis Complicated by Interstitial Lung DiseaseShogo Matsuda, Takuya Kotani, Hiroko Kuwabara, et al.
Rheumatology (Oxford, England)|January 25, 2021
CCL2 produced by CD68+/CD163+ macrophages as a promising clinical biomarker of microscopic polyangiitis-interstitial lung diseaseShogo Matsuda, Takuya Kotani, Hiroko Kuwabara, et al.
Rheumatology (Oxford, England)|August 26, 2023
Prediction model for respiratory-related mortality in microscopic polyangiitis with interstitial lung disease: multicentre REVEAL cohort studyShogo Matsuda, Takuya Kotani, Ayana Okazaki, et al.
Arthritis Research & Therapy|November 21, 2023
Risk prediction model for mortality in microscopic polyangiitis: multicentre REVEAL cohort studyTakuya Kotani, Shogo Matsuda, Ayana Okazaki, et al.
Rheumatology (Oxford, England)|July 20, 2019
Exploration of pathomechanism using comprehensive analysis of serum cytokines in polymyositis/dermatomyositis-interstitial lung diseaseShogo Matsuda, Takuya Kotani, Takaaki Ishida, et al.
Arthritis Research & Therapy|April 16, 2021
Comparison of the drug retention and reasons for discontinuation of tumor necrosis factor inhibitors and interleukin-6 inhibitors in Japanese patients with elderly-onset rheumatoid arthritis-the ANSWER cohort studySadao Jinno, Akira Onishi, Maureen Dubreuil, et al.
Scientific Reports|January 16, 2021
Evaluation of poor prognostic factors of respiratory related death in microscopic polyangiitis complicated by interstitial lung diseaseShogo Matsuda, Takuya Kotani, Takayasu Suzuka, et al.
Arthritis Research & Therapy|December 20, 2024
Poor prognostic factors for relapse of interstitial lung disease in microscopic polyangiitis: the Japanese multicentre REVEAL cohort studyShogo Matsuda, Takuya Kotani, Ayana Okazaki, et al.
Rheumatology International|July 31, 2020
Comparison of the efficacy and safety of biologic agents between elderly-onset and young-onset RA patients: the ANSWER cohort studySadao Jinno, Akira Onishi, Maureen Dubreuil, et al.
Clinical Rheumatology|March 13, 2020
Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort studyKosuke Ebina, Toru Hirano, Yuichi Maeda, et al.
Pageof 13